Dr. Angus Nairn

Biography

Angus Nairn completed his undergraduate training in biochemistry at the University of Edinburgh, Scotland, followed by a PhD in muscle biochemistry from the University of Birmingham, England. After his doctoral studies, he conducted postdoctoral research in molecular neuroscience under the mentorship of Professor Paul Greengard. In 1983, he joined the faculty at Yale University, where he currently serves as the Charles B.G. Murphy Professor of Psychiatry. He holds a joint appointment in the Department of Pharmacology and acts as the co-director of the Yale/National Institute of Drug Abuse Neuroproteomics Center at the Yale School of Medicine. His research focuses on the discovery and characterization of striatal phosphoproteins that are regulated by dopamine, providing insight into the molecular mechanisms underlying neuropsychiatric disorders. Nairn's work employs biochemical and molecular methods in combination with mouse models to assess the role of various proteins in signal transduction pathways within striatal neurons, aiming to elucidate their functions in dopamine-regulated behaviors.

Research Interests